Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 613-617

  Dominguez Herrera J ^a   Docobo Perez F ^a   Lopez Rojas R ^a   Pichardo, C ^a   Ruiz Valderas, R ^a   Lepe, J A ^a   Pachon J ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; BLOOD CULTURE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL MODEL; FEMALE; FOREIGN BODY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPENIA; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CATHETERS, INDWELLING; COLONY COUNT, MICROBIAL; DAPTOMYCIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIVER; METHICILLIN RESISTANCE; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84856076454     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05606-11     Document Type: Article

References (28)

1. Ahlstrand E, Svensson K, Persson L, Tidefelt U, Söderquist B. 2011. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. Eur. J. Clin. Microbiol. Infect. Dis. 30:1349-1354.
2. Christensen GD, et al. 1985. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006. (Pubitemid 16222727)
3. Clinical and Laboratory Standards Institute. 2010.Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20. CLSI, Wayne, PA.
4. Conen A, et al. 2008. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period. Clin. Infect. Dis. 47:73-82. (Pubitemid 351920591)
5. Craig WA, Andes DR. 2008. In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models. Antimicrob. Agents Chemother. 52:3492-3496.
6. Domínguez-Herrera J, Docobo-Perez F, López-Rojas R, Pichardo C, Pachón J. 2011. Abstr. 21st Eur. Congr. Clin. Microbiol. Infect. Dis./27th Int. Congr. Chemother., Milan, Italy, 7 to 10 May 2011, abstr P1069.
7. Freeman DJ, Falkiner FR, Keane CT. 1989. New method for detecting slime production by coagulase negative staphylococci. J. Clin. Pathol. 42:872-874. (Pubitemid 19190761)
8. Garcia I, del Carmen Conejo M, Ojeda A, Rodriguez-Bano J, Pascual A. 2010. A dynamic in vitro model for evaluating antimicrobial activity against bacterial biofilms using a new device and clinical-used catheters. J. Microbiol. Methods 83:307-311.
9. Garcia-de-la-Maria C, et al. 2010. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis. Antimicrob. Agents Chemother. 54:2781-2786.
10. Garnacho-Montero J, et al. 2008. Risk factors and prognosis of catheter-related bloodstream infection in critically ill patients: a multicenter study. Intensive Care Med. 34:2185-2193.
11. Healy DP, Polk RE, Garson ML, Rock DT, Comstock TJ. 1987. Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrob. Agents Chemother. 31:393-397. (Pubitemid 17027127)
12. Jimenez-Mejias ME, Garcia-Cabrera E. 2008. Infection of cerebrospinal fluid shunt systems. Enferm. Infecc. Microbiol. Clin. 26:240-251. (In Spanish.) (Pubitemid 351534799)
13. Klassen M, Edberg S. 1996. Measurement of antibiotic in human body fluids: techniques and significance, p 230-295. In Lorian V (ed), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, MD.
14. Lomas JM, et al. 2010. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin. Microbiol. Infect. 16:1683-1690.
15. Mermel LA, et al. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
16. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents.NCCLS document M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
17. National Nosocomial Infections Surveillance System. 2004. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32:470-485.
18. Olson ME, Slater SR, Rupp ME, Fey PD. 2010. Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm. J. Antimicrob. Chemother. 65:2164-2171.
19. Pichardo C, et al. 2011. Local imipenem activity against Pseudomonas aeruginosa decreases in vivo in the presence of siliconized latex. Eur. J. Clin. Microbiol. Infect. Dis. 30:289-291.
20. Quist SR, Fierlbeck G, Seaton RA, Loeffler J, Chaves RL. 2012. Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections. Int. J. Antimicrob. Agents. 39:90-91.
21. Rogers KL, Fey PD, Rupp ME. 2009. Coagulase-negative staphylococcal infections. Infect. Dis. Clin. North Am. 23:73-98.
22. Singh R, Ray P, Das A, Sharma M. 2010. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 65:1955-1958.
23. Stewart PS, Davison WM, Steenbergen JN. 2009. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 53:3505-3507.
24. Tobin CM, Darville JM, Lovering AM, Macgowan AP. 2008. An HPLC assay for daptomycin in serum. J. Antimicrob. Chemother. 62:1462-1463.
25. Uckay I, et al. 2009. Foreign body infections due to Staphylococcus epidermidis. Ann. Med. 41:109-119.
26. Van Praagh AD, et al. 2011. Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections. Antimicrob. Agents Chemother. 55:4081-4089.
27. Woodworth Jr, Nyhart EH Jr, Brier GL, Wolny JD, Black HR. 1992. Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers. Antimicrob. Agents Chemother. 36:318-325.
28. Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.